Trade group Pharmaceutical Research and Manufacturers of America (PhRMA) recently submitted comments to inform the Office of ...

China’s National Medical Products Administration (NMPA) in China has recently approved Sichuan Kelun Biotech’s Sutaray (trastuzumab botidotin) for the treatment of adult patients with unresectable or ...

In a further step in South Korea-based Celltrion’s ambitions to diversify from its core biosimilars focus, the company has ...

US pharma giant Pfizer (NYSE: PFE) reported financial results for the third quarter of 2025 on Tuesday. Revenues for the ...

US pharma major Eli Lilly has revealed plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands, ...

US biopharma Vertex Pharmaceuticals has reported consolidated financial results for the third quarter of 2025 and refined its ...

The bidding war for US obesity focused biotech Metsera, which has attracted offers from Pfizer and Novo Nordisk , and ...

US pharma giant Merck & Co, known as MSD outside of the USA and Canada, today announced that the company, through subsidiary ...

Swiss specialty drugmaker Santhera Pharmaceuticals saw its shares rise 5.8% to 10.90 francs today, after it reported positive ...

Italy based clinical-stage biotech AAVantgarde Bio today announced the successful closing of a $141 million (122 million ...

The US Food and Drug Administration (FDA) has approved Belgium drugmaker UCB’s Kygevvi (doxecitine and doxribtimine) powder ...

German pharma major Boehringer Ingelheim has broadened its collaboration with Swiss biotech CDR-Life through a global licensing agreement for CDR111, a trispecific M-gager designed to treat autoimmune ...